Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Asset Utilization Ratio (2011 - 2026)

Utah Medical Products' quarterly Asset Utilization Ratio came in at 0.3 in Q1 2026, down 5.16% year-on-year from 0.32 in Q1 2025, and down 3.51% quarter-over-quarter from 0.32 in Q4 2025.

Utah Medical Products has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.3 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio fell 5.16% year-over-year to 0.3; the trailing twelve-month figure through Mar 2026 stood at 0.3 (down 5.16% YoY), and the FY2025 full-year result was 0.31, down 0.86% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.3, down from 0.32 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.44 in Q3 2022, with the low at 0.3 in Q1 2026.
  • Average Asset Utilization Ratio over 5 years is 0.37, with a median of 0.36 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio climbed 14.63% in 2022 and declined 13.89% in 2024.
  • Tracing UTMD's Asset Utilization Ratio over 5 years: stood at 0.43 in 2022, then slipped by 12.73% to 0.38 in 2023, then retreated by 13.89% to 0.32 in 2024, then retreated by 2.85% to 0.32 in 2025, then declined by 3.51% to 0.3 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.3 (Q1 2026), 0.32 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn 0.30

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.30
Dec 31, 2025 0.32
Sep 30, 2025 0.32
Jun 30, 2025 0.32
Mar 31, 2025 0.32
Dec 31, 2024 0.32
Sep 30, 2024 0.34
Jun 30, 2024 0.35
Mar 31, 2024 0.36
Dec 31, 2023 0.38
Sep 30, 2023 0.39
Jun 30, 2023 0.40
Mar 31, 2023 0.42
Dec 31, 2022 0.43
Sep 30, 2022 0.44
Jun 30, 2022 0.43
Mar 31, 2022 0.43
Dec 31, 2021 0.42
Sep 30, 2021 0.41
Jun 30, 2021 0.40
Mar 31, 2021 0.37
Dec 31, 2020 0.39
Sep 30, 2020 0.40
Jun 30, 2020 0.43
Mar 31, 2020 0.44
Dec 31, 2019 0.44
Sep 30, 2019 0.43
Jun 30, 2019 0.41
Mar 31, 2019 0.41
Dec 31, 2018 0.42
Sep 30, 2018 0.43
Jun 30, 2018 0.43
Mar 31, 2018 0.44
Dec 31, 2017 0.45
Sep 30, 2017 0.45
Jun 30, 2017 0.47
Mar 31, 2017 0.50
Dec 31, 2016 0.49
Sep 30, 2016 0.49
Jun 30, 2016 0.49
Mar 31, 2016 0.50
Dec 31, 2015 0.50
Sep 30, 2015 0.51
Jun 30, 2015 0.54
Mar 31, 2015 0.53
Dec 31, 2014 0.51
Sep 30, 2014 0.49
Jun 30, 2014 0.48
Mar 31, 2014 0.49
Dec 31, 2013 0.50
Sep 30, 2013 0.51
Jun 30, 2013 0.53
Mar 31, 2013 0.53
Dec 31, 2012 0.53
Sep 30, 2012 0.53
Jun 30, 2012 0.53
Mar 31, 2012 0.54
Dec 31, 2011 0.49
Sep 30, 2011 0.43